OPERATING SEGMENTS (Tables)

12 Months Ended

Dec. 31, 2017

Disclosure of operating segments [abstract]

Schedule of Revenues and Operating Loss by Segments

The following table presents our revenues and operating loss by segments:

	Evogene			Evofuel			Biomica			Adjustments		Total
For the Year Ended December 31, 2017
Revenues	$	3,247		$	134		$	-		$	-	$	3,381
Operating loss	$	(21,430	)	$	(313	)	$	(204	)	$	-	$	(21,947	)
Net financing income												$	1,120
Loss before taxes on income												$	(20,827	)

	Evogene			Evofuel			Adjustments		Total
For the Year Ended December 31, 2016
Revenues	$	6,540		$	-		$	-	$	6,540
Operating loss	$	(20,168	)	$	(921	)	$	-	$	(21,089	)
Net financing income										1,533
Loss before taxes on income									$	(19,556	)

	Evogene			Evofuel			Adjustments		Total
For the Year Ended December 31, 2015
Revenues	$	11,129		$	-		$	-	$	11,129
Operating loss	$	(16,146	)	$	(1,775	)	$	-	$	(17,921	)
Net financing income										708
Loss before taxes on income									$	(17,213	)

Schedule of Major Customers

Revenues from major customers each of whom amounts to 10% or more, of total revenues:

	Year ended December 31,
	2017			2016			2015
Customer A (shareholder)		66	%		77	%		77	%
Customer B		10	%		12	%		-
Customer C		*) -			11	%		14	%

*) Represents an amount lower than 10%.

Schedule of Geographical Information

Revenues based on the location of the customers, are as follows::

	Year ended December 31,
	2017			2016			2015
United States		76	%		89	%		86	%
Germany		10	%		11	%		14	%
Other		14	%		-			-
		100	%		100	%		100	%